AURA 2023 includes data and analyses from 2020–2022 (primarily 2020–2021) from various sources and reports on patterns and trends in antimicrobial use and appropriateness and antimicrobial resistance (AMR) in Australian acute and community healthcare settings.
The Antimicrobial Use and Resistance in Australia (AURA) Surveillance System collects, reviews and analyses data on antimicrobial use and antimicrobial resistance in human health.
This complete version of the Opioid Analgesic Stewardship in Acute Pain Clinical Care Standard describes what each quality statement means for patients and their families, clinicians, and health service organisations, and provides indicators for local monitoring. It includes information about using clinical care standards, and the background and evidence sources for this standard.
This issue includes items on use of chlorhexidine, diagnostic safety, mental health, ambulance services, open disclosure, audit and feedback, and more.
Also covered are the latest from BMJ Quality &Safety, International Journal for Quality in Health Care and the USA’s AHRQ.
This issue includes items on governance, health systems, and more.
Also covered are the latest from BMJ Quality &Safety, The Joint Commission Journal on Quality and Patient Safety, American Journal of Medical Quality, Public Health Research & Practice, BMJ Leader and the UK’s NIHR and the USA’s AHRQ.
This Advisory outlines actions in the National Safety and Quality Mental Health Standards for Community Managed Organisations (NSQMHCMO Standards) that may not be applicable to a Service Provider. The Commission has issued this advisory to ensure accrediting agencies consistently apply not applicable status to actions within the NSQMHCMO Standards.
This issue includes items on the cleaning and disinfection of ultrasound transducers, digital health, and more.
Also covered are the latest from BMJ Quality &Safety, Journal for Healthcare Quality, HealthcarePapers and the International Journal for Quality in Health Care.
This fact sheet provides guidance on the storage and management of concentrated 80% phenol in Australian clinical settings, other than podiatry.
This issue includes items on medication safety, patient safety, co-design, surgery, second victim syndrome, 30-day mortality and more.
Also covered are the latest from Australian Health Review, JBI Evidence Synthesis, BMJ Quality &Safety, International Journal for Quality in Health Care and the USA’s AHRQ.
The Commission's Innovate RAP focuses on empowering and strengthening relationships with Aboriginal and Torres Strait Islander peoples and piloting strategies for further reconciliation commitments.